| Literature DB >> 11991674 |
Ewert Schulte-Frohlinde1, Barbara Seidler, Ines Burkard, Tobias Freilinger, Christian Lersch, Volker Erfle, Graham R Foster, Meinhard Classen.
Abstract
The type I interferons (IFNs) are a group of closely related cytokines which have different signal transduction pathways and different biological activities. Using transient transfection of human hepatoma cells with reporter plasmids containing the firefly/renilla luciferase genes under the control of the HBV-Enhancer (Enh) I, Enh II and core promoter we have investigated the biological activities of 10 recombinant (r) type I IFNs on transcription. Low concentrations of IFN (0.025 ng/ml) had a significant and specific inhibitory effect but the potencies of the different recombinant type I IFNs differed markedly with IFNalpha8 and IFNbeta being six-fold more potent than the least effective subtype (IFNalpha1). However, the addition of IFNalpha5-the subtype produced predominantly in the human liver-did not cause any synergistic effects.The non-natural consensus IFN displayed a more pronounced inhibition of HBV-regulated transcription than IFNalpha8 or IFNalpha2 but not IFNbeta. The INF-induced inhibitory effect was not dependent on the presence of the HBV-Enh1 and in particular of an interferon stimulated response element (ISRE)-like sequence. The characterization of different effects among type I interferons on HBV-regulatory elements may implicate an IFN-subtype-specific role for the pathogenesis and treatment of HBV-infection. Copyright 2002 Elsevier Science Ltd. All rights reserved.Entities:
Mesh:
Substances:
Year: 2002 PMID: 11991674 DOI: 10.1006/cyto.2001.1000
Source DB: PubMed Journal: Cytokine ISSN: 1043-4666 Impact factor: 3.861